Breadcrumb
  1. Home
  2. Data & Reporting
  3. Health Center COVID-19 Survey
  4. Virginia Health Center COVID-19 Survey Summary Report

Virginia Health Center COVID-19 Survey Summary Report

Latest data from June 17, 2022

Number of Health Center respondents = 18 (69% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 1,981
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 49.52%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 308
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 35.59%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 48.21% 61.69%
White, Hispanic/Latino Patients 15.50% 5.19%
Black/African American, Non-Hispanic/Latino Patients 21.10% 22.08%
Black/African American, Hispanic/Latino Patients 0.76% 0.32%
Asian Patients3 2.02% 2.60%
American Indian/Alaska Native Patients3 0.40% 0.65%
Native Hawaiian/Other Pacific Islander Patients3 0.20% 0.00%
Patients with More Than One Race3 1.16% 0.32%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 6.16% 2.92%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.51% 2.92%
Unreported/Refused to Report Race and Ethnicity 2.98% 1.30%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 118
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 81.42%
COVID-19 Immunization Series Completed 84
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 78.38%
COVID-19 Immunization Series Additional 941
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 58.39%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 17.80% 19.05% 40.06%
White, Hispanic/Latino Patients 40.68% 32.14% 10.63%
Black/African American, Non-Hispanic/Latino Patients 22.03% 19.05% 23.38%
Black/African American, Hispanic/Latino Patients 0.00% 0.00% 0.43%
Asian Patients3 5.08% 7.14% 2.02%
American Indian/Alaska Native Patients3 1.69% 0.00% 16.79%
Native Hawaiian/Other Pacific Islander Patients3 0.00% 0.00% 0.00%
Patients with More Than One Race3 0.85% 1.19% 0.21%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 7.63% 9.52% 2.76%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 2.54% 4.76% 1.81%
Unreported/Refused to Report Race and Ethnicity 1.69% 7.14% 1.91%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 22.22%
1 to 24 Hours 38.89%
More Than 24 Hours 33.33%
N/A 5.56%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 11.11%
Vaccine confidence 44.44%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 11.11%
None 38.89%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 22.22%
Average Percent of Health Center Visits Conducted Virtually 9.44%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 22.22%
Number of Mobile Van Sites 3
Number of Pop-up Clinics 4
Number of School-Based Vaccination Sites 0
Number of Family Vaccination Clinics 0

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 55.56%
None 44.44%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 11.11%
Patient awareness/education 5.56%
Staffing capacity 16.67%
Therapy administration/onsite logistics 11.11%
Other 5.56%
None 55.56%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 10
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 3,574

Test Kit Distribution Methods4

Metrics Value
Provided to Existing Health Center Patients 90.00%
Provided to General Public Who Came to the Health Center 50.00%
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 20.00%
Provided at Other Community Events 60.00%
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals 30.00%
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals 30.00%
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals 20.00%
Provided to school-age children and/or their families directly or through partnerships with schools 20.00%
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities 20.00%
Other 0.00%

N95 Mask Distribution

Metrics Value
Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program 9
Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program 1,998

N95 Mask Distribution Methods5

Metrics Value
Provided to Existing Health Center Patients 77.78%
Provided to General Public Who Came to the Health Center 66.67%
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 22.22%
Provided at Other Community Events 44.44%
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals 33.33%
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals 33.33%
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals 22.22%
Provided to school-age children and/or their families directly or through partnerships with schools 22.22%
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities 22.22%
Other 0.00%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 1
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication 83.33%

Oral Antiviral Medication Distribution by Race and Ethnicity

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients 11.11%
White, Hispanic/Latino Patients 16.67%
Black/African American, Non-Hispanic/Latino Patients 16.67%
Black/African American, Hispanic/Latino Patients 0.00%
Asian Patients3 50.00%
American Indian/Alaska Native Patients3 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.00%
Patients with More Than One Race3 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.00%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 5.56%
Unreported/Refused to Report Race and Ethnicity 0.00%

Oral Antiviral Medication Distribution by Population Type

Metrics Value
Migratory/Agricultural Workers 0.00%
Patients Experiencing Homelessness 0.00%
Patients Who Are Residents of Public Housing 0.00%
Patients with Limited English Proficiency 5.56%
Children Under 18 Years of Age 0.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.

Date Last Reviewed: